Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2025-12-25 @ 4:02 AM
NCT ID:
NCT03244202
Eligibility Criteria:
Inclusion Criteria:
* Patients with a family history of cancer
* Received a negative single gene test for a cancer gene mutation (e.g., BRCA1/2, MLH, MSH, PMS, etc.) or received a negative panel test
* Speak and read English
Exclusion Criteria:
* Are in advanced stage cancer (stage 5)
* Received positive panel testing or panel sequencing
* Have not had single gene testing related to their primary cancer condition (e.g., BRCA1/2 for breast/ovarian cancer, MLH, MSH, PMS colorectal cancer, etc.)
* Received a positive genetic test for a cancer gene mutation (e.g., BRCA1/2, MLH, MSH, PMS, APC, MUTYH, etc.)
* Do not speak or read English
* Family member participating in the study
* Participant in usability study of the DA
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03244202
Study Brief:
Protocol Section:
NCT03244202